So-Hyun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
So-Hyun Park has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Chang Hwa Jung
Aging and Metabolism Research Group, Korea Food Research Institute, Wanju-Gun, Republic of Korea
7 shared publications Hyo-Deok Seo
Aging Research Group, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, South Korea
4 shared publicationsJeong-Hoon Hahm
Aging Research Group, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, South Korea; Department of Food Biotechnology, University of Science and Technology, Wanju-gun, Jeollabuk-do, South Korea
4 shared publicationsJiyun Ahn
Aging Research Group, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, South Korea; Department of Food Biotechnology, University of Science and Technology, Wanju-gun, Jeollabuk-do, South Korea
4 shared publications- Pyeong Geun Choi
Aging Research Group, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, South Korea; Department of Food Biotechnology, University of Science and Technology, Wanju-gun, Jeollabuk-do, South Korea
3 shared publications Daedong Kim
Research Center, DAESANG InnoPark, Gangseo-gu, Seoul, 07789, South Korea
2 shared publications
Latest Publications
- Open Access
- 31 January 2026
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 59 (1) , 51-59
Precision geronutrition: personalized nutritional strategies to extend healthy lifespan
So-Hyun Park, Chang Hwa Jung & Jiyun Ahn. BMB Reports 2026;59:51-9. https://doi.org/10.5483/BMBRep.2025-0216
- 31 January 2026
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 59 (1) , 51-59
Open AccessPrecision geronutrition: personalized nutritional strategies to extend healthy lifespan
So-Hyun Park, Chang Hwa Jung & Jiyun Ahn. BMB Reports 2026;59:51-9. https://doi.org/10.5483/BMBRep.2025-0216
- Open Access
- 25 November 2025
- Published by Elsevier in Phytomedicine
- Vol. 150, 157609
Justicia procumbens promotes hair growth and ameliorates age-related deterioration of hair health
- 25 November 2025
- Published by Elsevier in Phytomedicine
- Vol. 150, 157609
Open AccessJusticia procumbens promotes hair growth and ameliorates age-related deterioration of hair health
- Open Access
- 22 April 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 80, 1031-1044
Niclosamide extends health span and reduces frailty by ameliorating mTORC1 hyperactivation in aging models
- 22 April 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 80, 1031-1044
Open AccessNiclosamide extends health span and reduces frailty by ameliorating mTORC1 hyperactivation in aging models
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
2′‐Fucosyllactose Alleviates Hair Loss in Testosterone‐Induced Androgenic Alopecia Mice
2′‐Fucosyllactose (2′‐FL) is a component of human milk oligosaccharides and has undergone extensive investigation for potential health benefits. However, its potential to prevent androgenic alopecia (AGA) has not been reported. In this study, we investigated the protective effect of 2′‐FL on hair damage in a testosterone‐induced AGA mouse model. The administration of 2′‐FL significantly reduced hair loss and increased both hair length and thickness in an AGA mouse model. Mechanistically, administration of 2′‐FL increased hair follicle size and growth factor expression associated with hair growth. 2′‐FL enhanced β‐catenin signaling by activating AKT and ERK. In addition, 2′‐FL suppressed apoptosis signaling and inflammatory cytokines in the dorsal skin of AGA mice. These results underscore the potential of 2′‐FL as a therapeutic agent for AGA.
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Open Access2′‐Fucosyllactose Alleviates Hair Loss in Testosterone‐Induced Androgenic Alopecia Mice
2′‐Fucosyllactose (2′‐FL) is a component of human milk oligosaccharides and has undergone extensive investigation for potential health benefits. However, its potential to prevent androgenic alopecia (AGA) has not been reported. In this study, we investigated the protective effect of 2′‐FL on hair damage in a testosterone‐induced AGA mouse model. The administration of 2′‐FL significantly reduced hair loss and increased both hair length and thickness in an AGA mouse model. Mechanistically, administration of 2′‐FL increased hair follicle size and growth factor expression associated with hair growth. 2′‐FL enhanced β‐catenin signaling by activating AKT and ERK. In addition, 2′‐FL suppressed apoptosis signaling and inflammatory cytokines in the dorsal skin of AGA mice. These results underscore the potential of 2′‐FL as a therapeutic agent for AGA.
- Open Access
- 27 December 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 115913
Justicia procumbens prevents hair loss in androgenic alopecia mice
- 27 December 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 115913
Open AccessJusticia procumbens prevents hair loss in androgenic alopecia mice
- 9 August 2023
- Published by Elsevier in Food Bioscience
- Vol. 55
C-Glycosidic flavone-rich Passiflora incarnata L. leaf extracts decrease body weight and fatty liver in obese mice
- 9 August 2023
- Published by Elsevier in Food Bioscience
- Vol. 55
C-Glycosidic flavone-rich Passiflora incarnata L. leaf extracts decrease body weight and fatty liver in obese mice
- Open Access
- 4 June 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-11
Autophagy Functions to Prevent Methylglyoxal-Induced Apoptosis in HK-2 Cells
Methylglyoxal (MGO), a reactive carbonyl species, causes cellular damage and is closely related to kidney disease, particularly diabetic nephropathy. Although MGO has been reported to induce autophagy and apoptosis, the relationships between the two pathways are unclear. Here, we evaluated whether autophagy may be the underlying mechanism inhibiting MGO-induced apoptosis. MGO treatment induced concentration- and time-dependent apoptosis in HK-2 cells. Moreover, MGO upregulated the autophagy markers p62 and LC3-II. Apoptosis caused by MGO was increased in ATG5-knockdown cells compared to that in wild-type cells. In contrast, autophagy activation by 5-aminoimidazole-4-carboxamide ribonucleotide resulted in reduced apoptosis, suggesting that autophagy played a role in protecting against MGO-induced cell death. To examine the mechanisms through which autophagy occurred following MGO stimulation, we investigated changes in AKT/mammalian target of rapamycin (mTOR) signaling. Autophagy induction by MGO treatment was not related to AKT/mTOR signaling; however, it did involve autophagy-related gene expression promoted by AMP-activated protein kinase-mediated transcription factors, such as forkhead box 1. Overall, our findings indicate that MGO-induced cellular damage can be mitigated by autophagy, suggesting that autophagy may be a potential therapeutic target for diseases such as diabetic nephropathy.
- 4 June 2020
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-11
Open AccessAutophagy Functions to Prevent Methylglyoxal-Induced Apoptosis in HK-2 Cells
Methylglyoxal (MGO), a reactive carbonyl species, causes cellular damage and is closely related to kidney disease, particularly diabetic nephropathy. Although MGO has been reported to induce autophagy and apoptosis, the relationships between the two pathways are unclear. Here, we evaluated whether autophagy may be the underlying mechanism inhibiting MGO-induced apoptosis. MGO treatment induced concentration- and time-dependent apoptosis in HK-2 cells. Moreover, MGO upregulated the autophagy markers p62 and LC3-II. Apoptosis caused by MGO was increased in ATG5-knockdown cells compared to that in wild-type cells. In contrast, autophagy activation by 5-aminoimidazole-4-carboxamide ribonucleotide resulted in reduced apoptosis, suggesting that autophagy played a role in protecting against MGO-induced cell death. To examine the mechanisms through which autophagy occurred following MGO stimulation, we investigated changes in AKT/mammalian target of rapamycin (mTOR) signaling. Autophagy induction by MGO treatment was not related to AKT/mTOR signaling; however, it did involve autophagy-related gene expression promoted by AMP-activated protein kinase-mediated transcription factors, such as forkhead box 1. Overall, our findings indicate that MGO-induced cellular damage can be mitigated by autophagy, suggesting that autophagy may be a potential therapeutic target for diseases such as diabetic nephropathy.
- Open Access
- 1 March 2016
- Published by Walter de Gruyter GmbH in Archives of Polish Fisheries
- Vol. 24 (1) , 23-32
Protective efficiency of an inactivated vaccine against Streptococcus iniae in olive flounder, Paralichthys olivaceus
Streptococcus iniae is a causative agent of hemorrhagic septicemia in olive flounder, Paralichthys olivaceus, in Korea, resulting in serious economic losses. As a preventive measure, M VAC INIAE (Mastuken, Japan) was prepared from the S. iniae F2K strain and tested against the SI-36 strain prevalent on flounder fish farms on Jeju Island, Korea. F2K had a serotype of 38 (−) and SI-36 38 (+). The vaccine recognized both serotypes. It showed a very high effective immune response against S. iniae; the challenge test using the S. iniae SI-36 strain resulted in a relative percent survival (RPS) of 85.7-87.0% 2 weeks after vaccination and 71.0-80.0% 6 months after vaccination. Field vaccination and clinical challenge tests were performed at local Jeju aquafarms with S. iniae SI-36. These showed significantly reduced cumulative mortality when compared to the control group with RPS rates that ranged between 71-80%. Hence, the present study suggests that this vaccine showed a significant immune response against S. iniae and could be applied in commercial aquafarms as a therapeutic agent against β-hemolytic streptococcosis in cultured P. olivaceus.
- 1 March 2016
- Published by Walter de Gruyter GmbH in Archives of Polish Fisheries
- Vol. 24 (1) , 23-32
Open AccessProtective efficiency of an inactivated vaccine against Streptococcus iniae in olive flounder, Paralichthys olivaceus
Streptococcus iniae is a causative agent of hemorrhagic septicemia in olive flounder, Paralichthys olivaceus, in Korea, resulting in serious economic losses. As a preventive measure, M VAC INIAE (Mastuken, Japan) was prepared from the S. iniae F2K strain and tested against the SI-36 strain prevalent on flounder fish farms on Jeju Island, Korea. F2K had a serotype of 38 (−) and SI-36 38 (+). The vaccine recognized both serotypes. It showed a very high effective immune response against S. iniae; the challenge test using the S. iniae SI-36 strain resulted in a relative percent survival (RPS) of 85.7-87.0% 2 weeks after vaccination and 71.0-80.0% 6 months after vaccination. Field vaccination and clinical challenge tests were performed at local Jeju aquafarms with S. iniae SI-36. These showed significantly reduced cumulative mortality when compared to the control group with RPS rates that ranged between 71-80%. Hence, the present study suggests that this vaccine showed a significant immune response against S. iniae and could be applied in commercial aquafarms as a therapeutic agent against β-hemolytic streptococcosis in cultured P. olivaceus.